ROBERTO PADRON: Open Payments
NPI 1750136644 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$662 in 26 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $61 · 2025 $662
Food & beverage: $662
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $204 |
| Axsome Therapeutics, Inc. | 6 | $198 |
| Alkermes, Inc. | 9 | $176 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| Orexo US, Inc. | 1 | $28 |
| Luye Pharma (USA) Ltd. | 1 | $24 |
Products named: VRAYLAR, Auvelity, ARISTADA, VIVITROL, ABILIFY MAINTENA, Zubsolv, ERZOFRI EXTENDED-RELEASE, LYBALVI.
Industry payments across FL — which companies pay providers there.
